Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × ceritinib × Clear all

NCT02374489 2018-04-05

A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma

Phase 2 Terminated

Gastrointestinal

Cholangiocarcinoma

NCT02638909 2018-04-02

Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma Of Esophagus, Cholangiocarcinoma